Abstract: Provided are a vehicle chassis and a vehicle, which are related to a field of vehicle technology, in particular to fields of automatic driving technology and driving test technology. The vehicle chassis includes: a chassis support, a steering system, an electrical system, a driving system, and two brake systems. The chassis support is provided with a steering system mounting site, an electrical system mounting site, a driving system mounting site, and two brake system mounting sites; which are arranged in sequence along a length direction of the vehicle chassis. A first brake system mounting site is disposed between the steering system mounting site and the electrical system mounting site; and a second brake system mounting site is disposed between the driving system mounting site and the electrical system mounting site. The two brake systems, the driving system and the steering system are communicatively connected to the electrical system.

Abstract: The present invention is an immersion liquid supply and recovery device (2) with new-type pumping and drainage cavities.

Abstract: A multiple-path amplifier (e.g., a Doherty amplifier) includes first and second transistors (e.g., main and peaking transistors) with first and second output terminals, respectively, all of which is integrally-formed with a semiconductor die. A signal path through the second transistor extends in a direction from a control terminal of the second transistor to the second output terminal, where the second output terminal corresponds to or is closely electrically coupled to a combining node. The amplifier also includes an integrated phase delay circuit that is configured to apply an overall phase delay (e.g., 90 degrees) to a signal carried between the first and second output terminals. The integrated phase delay circuit includes delay circuit wirebonds coupled between the first and second output terminals, and the delay circuit wirebonds extend in a third direction that is angularly offset from (e.g., perpendicular to) the second direction.

Abstract: A unit plate position fixation method and device and a lamination machine are provided. The unit plate position fixation method includes: obtaining peripheral position information of unit plates located between two layers of separators; controlling a hot-pressing device according to the peripheral position information to perform hot pressing on the two layers of separators, so that the two layers of separators are adhered at peripheral positions of the unit plates.

Abstract: A method, an apparatus and a system for controlling charging of a battery module are provided in the present disclosure. The method for controlling charging of the battery module may include: acquiring an internal pressure value of the battery module; determining a target pressure threshold range to which the acquired internal pressure value of the battery module belongs, based on a plurality of predefined pressure threshold ranges; obtaining a target charge cutoff voltage corresponding to the target pressure threshold range, based on a correspondence relationship between a plurality of predefined charge cutoff voltage and the plurality of predefined pressure threshold ranges; and controlling the battery module to be charged based on the obtained target charge cutoff voltage.

Abstract: The invention discloses a laminated cell structure, the laminated cell structure comprising a top cell unit, a bottom cell unit, and an intermediate layer located between the top cell unit and the bottom cell unit; the intermediate layer being configured as a tunnel junction composed of a p+/n+ double-layer silicon thin film; the top cell unit comprising an electron transport layer, a perovskite photosensitive layer, a hole transport layer sequentially laminated in the direction from the distance to the vicinity with respect to the intermediate layer, and a front electrode provided on the electron transport layer; and the bottom cell unit being a PERC solar cell. The invention also correspondingly discloses a preparation method for the laminated cell structure. According to the invention, good perovskite cell performance can be obtained by adopting a silicon thin film tunnel junction structure. The laminated cell with the structure has high photoelectric conversion efficiency.

Abstract: In some aspects, the present disclosure provides vaccine compositions comprising an antigen and a diblock copolymer wherein the diblock copolymer is pH responsive. In some embodiments, these compositions activate the STING and/or the interferon receptor pathways. In some embodiments, the diblock copolymer hits a pKa from about 6 to about 7.5. Also provided herein are methods of treatment using these compositions to treat an infectious disease or cancer.

Abstract: A method, an apparatus and a system for controlling charging of a battery module are provided in the present disclosure. The method for controlling charging of the battery module may include: acquiring an internal pressure value of the battery module; determining a target pressure threshold range to which the acquired internal pressure value of the battery module belongs, based on a plurality of predefined pressure threshold ranges; obtaining a target charge cutoff voltage corresponding to the target pressure threshold range, based on a correspondence relationship between a plurality of predefined charge cutoff voltage and the plurality of predefined pressure threshold ranges; and controlling the battery module to be charged based on the obtained target charge cutoff voltage.

Abstract: The invention provides novel fusion proteins of Interleukin 12 and prodrugs, and compositions and methods of preparation thereof, useful in treating various diseases and disorders (e.g., hyperplasia, solid tumor or hematopoietic malignancy).

Abstract: The therapies described herein can be selectively lethal toward a variety of different cancer cell types and cancer conditions in a subject. The combination therapies described herein can be useful for the management, treatment, control, or adjunct treatment of diseases, where the selective lethality is beneficial in immunotherapy, particularly where the disease is accompanied by elevated levels of NQO1. In particular, embodiments where an immunotherapy, such as a heckpoint inhibitor, are combined with a NQO1 bioactivatable drug.

Abstract: The present invention discloses a film type liquid heater and a uniform heating method thereof. End fixation plates are arranged at two ends of a barrel. A heating pipe is arranged in the barrel. Pipe ports run through the two end fixation plates, respectively. Connecting pipes are arranged in the pipe ports. Sealing connection components are arranged at inner ends of the two connecting pipes. A heating film layer is coated outside the heating pipe. Electrode layers are connected left and right sides of the heating film layer, and the electrode layers are connected to an external power supply. An insulating layer is coated outside the heating film layer. A flow splitting column is fixedly connected in the heating pipe. A heating chamber is formed between an inner side of the heating pipe and the flow splitting column. Flow splitting grooves are formed at left and right ends and on the inner side of the flow splitting column.

Abstract: A drug-loaded, flexible and transparent composite material for use in bandages and bandage contact lenses to topically administer a medication in a sustained and effective way is described, as well as methods of fabrication and use thereof. The composite material comprises drug carrying porous nanoparticles embedded within a transparent, flexible polymeric matrix and, when applied as a bandage, provides topical drug delivery to a tissue, while protecting it from the environment, yet allowing facile examination due to transparency.

Abstract: A multiple-path amplifier (e.g., a Doherty amplifier) includes a semiconductor die, a radio frequency (RF) signal input terminal, a combining node structure integrally formed with the semiconductor die, and first and second amplifiers (e.g., main and peaking amplifiers) integrally formed with the die. Inputs of the first and second amplifiers are electrically coupled to the RF signal input terminal. A plurality of wirebonds is connected between an output of the first amplifier and the combining node structure. An output of the second amplifier is electrically coupled to the combining node structure (e.g., through a conductive path with a negligible phase delay). A phase delay between the outputs of the first and second amplifiers is substantially equal to 90 degrees. The second amplifier may be divided into two amplifier portions that are physically located on opposite sides of the first amplifier.

Abstract: The present application provides an application of Chidamide in combination with R-CHOP in preparing a drug used for treating B-cell lymphoma, and also provides a drug comprising Chidamide and R-CHOP. Chidamide in combination with R-CHOP has a synergistic therapeutic effect on B-cell lymphoma.

Abstract: A multiple-path (e.g., Doherty) amplifier includes a semiconductor die, a radio frequency (RF) signal input terminal, a combining node structure integrally formed with the semiconductor die, first and second amplifiers (e.g., main and peaking amplifiers, or vice versa) integrally formed with the semiconductor die, and a shunt circuit electrically connected between an output of the first amplifier and a ground reference node. Inputs of the first and second amplifier are electrically coupled to the RF signal input terminal, and outputs of the first and second amplifier are electrically coupled to the combining node structure. The shunt circuit includes a shunt inductance and a shunt capacitance coupled in series between the output of the first amplifier and the ground reference node, and the shunt capacitance has a first terminal coupled to the shunt inductance, and a second terminal coupled to the ground reference node.

Abstract: The present application relates to the technical field of medicine, and discloses an application of Chidamide. The present application provides for the application of a therapeutic schedule for using Chidamide in the treatment of B cell lymphoma, and verifies by clinical test the outstanding effect of Chidamide monotherapy for diffuse large B cell lymphoma and recurrent or refractory follicular lymphoma accompanied by specific epigenetic regulation gene mutation. The application can treat B cell lymphoma patients more effectively.

Abstract: A computer-implemented method for displaying rich text on a 3D model includes obtaining, by one or more processing devices, a target rich text; invoking a rendering tool corresponding to a file format of the target rich text; rendering the target rich text using the rendering tool, to obtain a rendering result; invoking a graphical programming interface; and texture mapping the rendering result to an area of the 3D model using the graphical programming interface.

Abstract: A power amplifier includes a semiconductor die, and an amplifier and bias circuit integrally formed with the semiconductor die. The die has opposed first and second sides, and a device bisection line extends between the first and second sides. The bias circuit includes a multi-point input terminal with first and second terminals that are electrically connected through a conductive path that extends across the device bisection line, and one or more bias circuit components connected between the multi-point input terminal and the amplifier. The amplifier may include a field effect transistor (FET) with gate and drain terminals, and the bias circuit component(s) are electrically connected between the multi-point input terminal and the gate terminal. In addition or alternatively, the bias circuit component(s) are electrically connected between a multi-point input terminal and the drain terminal. The one or more components may include a resistor-divider circuit.

Abstract: A range of alloys of Mg and at least one of Cu, Si, Ni and Na alloys that is particularly suitable for hydrogen storage applications. The alloys of the invention are formed into binary and ternary systems. The alloys are essentially hypoeutectic with respect to their Cu and Ni contents, where one or both of these elements are present, but range from hypoeutectic through to hypereutectic with respect to their Si content when that element is also present. The terms hypoeutectic and hypereutectic do not apply to Na if it is added to the alloy. The alloy compositions disclosed provide high performance alloys with regard to their hydrogen storage and kinetic characteristics. They are also able to be formed using conventional casting techniques which are far cheaper and more amenable to commercial use than the alternative ball-milling and rapid solidification techniques which are much more expensive and complex.

Abstract: Disclosed herein are methods of treatments with a telomerase-mediated telomere-targeting drug, 6-thio-2?-deoxyguanosine (6-thio-dG), checkpoint inhibitors and/or radiation therapy for treating cancers. eads to tumor regression in innate and adaptive immune-dependent manners in syngeneic and humanized mouse cancer models.